Top Alzheimer’s Research Stories of 2018

January is Alzheimer’s disease awareness month in Canada and Alzheimer’s Society chapters all over Canada are gearing towards raising awareness of the disease among Canadians. It is therefore, an appropriate time to sum up the top research stories on Alzheimer’s disease in 2018, as a reminder of the great work being done to develop treatments to improve the lives of individuals affected by dementia, to help physicians diagnose the disease early, and to identify interventions to reduce the risk of developing the disease.

The symptoms of Alzheimer’s Disease including problems with memory, thinking, behaviour, and inability to carry out daily living activities have been attributed to abnormal protein deposits in the brain, namely amyloid plaques and tau tangles.

In the realm of drug development for Alzheimer’s Disease, 2018 was a bitter-sweet year with some drugs failing to perform in human trials, and other drugs showing some early success.

Drug Trials: The most promising among these are immunotherapies — mainly, antibodies lowering amyloid (Aducanumab) or tau, and BACE inhibitors that reduce the formation of plaques.

Early studies have shown that Aducanumab can decrease amyloid in the brain to levels lower than that required for a PET scan to diagnose the disease. Later studies also confirmed its effectiveness in slowing down the progression of early to moderate disease.

Other anti-amyloid antibodies found beneficial in early Alzheimer’s disease and proceeding to final trials along with Aducanumab include Gantenerumab, Crenezumab, and BAN2401.

LMTM monotherapy, the only antibody targeting the abnormal tau deposits contributing to brain degeneration, has been approved for early trials in humans.

However, BACE inhibitor studies proved disappointing with 3 of their candidates Verubecestat, Atabecestat, and Lanabecestat worsening symptoms in trial participants. Nevertheless, one drug Elenbecestat has progressed to final trials with research community anxiously following their progress.

Bryostatin-1 is the only drug that has shown some potential in helping reverse symptoms in patients with moderate to severe Alzheimer’s, with sustained benefits.

Some drugs approved for other conditions, have been found promising as potential treatment for Alzheimer’s Disease in early studies. These include asthma medication Montelukast, diabetes drug Liraglutide, cancer drug Nilotinib, and epilepsy medication Levetiracetam.

Late 2018 brought the exciting news from University of Texas Southwestern Medical Center about their vaccine that could arm the body to attack Alzheimer’s plaques and tangles before they even start to shut down the brain. They hope to begin testing the vaccines in humans soon.

Researchers in Spain claimed they cleared amyloid from the brain by a plasma exchange process. A related approach of soothing the inflamed aging brain, either with whole plasma or defined fractions from the blood of young adults is in early stage trials.

Early Diagnosis: Efforts have been ongoing to develop tests to help physicians diagnose the disease early, and administer treatment. The much-awaited blood test is just around the corner, along with other non-invasive eye test, saliva test and cognitive test. These tests when available will help physicians identify people at risk of developing the disease up to 5 years ahead of time with accuracy.

Risk Reduction: Increasing recognition that it is easier to prevent dementia than to treat it has paved the way for extensive research in this direction and culminated in a multi-pronged approach to reduce risk. Risk reduction strategies with most evidence include regular physical exercise of moderate intensity (eg. brisk walking), for 30-45 minutes; engaging in life-long learning (learning a skill, language, musical instrument etc.) following a plant-based diet, such as Mediterranean diet; regulating blood pressure (120/80 ideally, or the lowest possible) and volunteering.

I hope that these top stories have helped you understand how you can reduce your risk of dementia and also raise hope among individuals diagnosed with Alzheimer’s disease and their families. Let us hope that 2019 will bring breakthroughs in treatments that may change the course of this devastating illness.

Padmaja Genesh, who holds a bachelor degree in medicine and surgery as well as a bachelor degree in Gerontology, has spent several years teaching and working with health care agencies. A past resident of Red Deer, and a past board member of Red Deer Golden Circle, she is now a Learning Specialist at the Alzheimer Society of Calgary. Please send your comments to padmajaganeshy@yahoo.ca

Just Posted

Trade, China sure to surface as Trudeau meets Trump, congressional leaders

WASHINGTON — Justin Trudeau is headed back to the White House today… Continue reading

Oil shippers boost security after mysterious attacks in Gulf

DUBAI, United Arab Emirates — A series of attacks on oil tankers… Continue reading

Canada could hit pot oversupply as early as 2019, depending on edibles: BDS

TORONTO — Canada could reach an oversupply of legal pot as soon… Continue reading

‘Minimum of nine bullets:’ Trial hears Manitoba Mountie shot man numerous times

THOMPSON, Man. — A forensic pathologist has testified that an RCMP officer… Continue reading

Trans Mountain CEO says shovels could be in ground on pipeline by September

CALGARY — The CEO of the Crown corporation building the Trans Mountain… Continue reading

WATCH: New RDC president has three decades of experience working at colleges and universities

Peter Nunoda says he’s ‘excited’ to help transition the college into a university

‘He gets it’: Bowen Byram set to hear name called early at NHL draft

VANCOUVER — Bowen Byram’s bantam coach knew almost immediately the defenceman would… Continue reading

Guardado scores 2 as Mexico beats Canada 3-1

DENVER — Andres Guardado had two goals in the second half, Roberto… Continue reading

Toronto Maple Leafs star Auston Matthews on cover of “NHL 20” video game

Toronto Maple Leafs star forward Auston Matthews will be on the cover… Continue reading

‘350 Days’ wrestling documentary screens in Calgary before arriving on Amazon next month

CALGARY — A documentary exploring the golden era of professional wrestling had… Continue reading

Trans Mountain CEO says shovels could be in ground on pipeline by September

CALGARY — The CEO of the Crown corporation building the Trans Mountain… Continue reading

Alberta government looking to speed up job accreditation for foreign workers

EDMONTON — The Alberta government wants to ensure that foreign-trained professionals and… Continue reading

Tax credits, penalizing big polluters, key to Conservative climate plan

OTTAWA — Conservative Leader Andrew Scheer says his climate plan will be… Continue reading

Trudeau promises to legislate implementation of UNDRIP if re-elected

OTTAWA — Prime Minister Justin Trudeau is promising that a re-elected Liberal… Continue reading

Most Read